ARTICLE | Company News
curasan AG, CryoLife sales and marketing update
February 10, 2003 8:00 AM UTC
CRY received exclusive U.S. distribution rights to CUR's Cerasorb Ortho resorbable bone graft substitute for orthopedic indications. The deal excludes spine and dental applications. CRY also launched ...